Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Disability and its treatment in bipolar disorder patients.

Tytuł:
Disability and its treatment in bipolar disorder patients.
Autorzy:
Huxley N; The International Consortium for Bipolar Disorder Research, Department of Psychiatry, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, MA, USA. nancy_ />Baldessarini RJ
Źródło:
Bipolar disorders [Bipolar Disord] 2007 Feb-Mar; Vol. 9 (1-2), pp. 183-96.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
Język:
English
Imprint Name(s):
Publication: Copenhagen : Wiley-Blackwell Munksgaard
Original Publication: Copenhagen, Denmark : Munksgaard, 1999-
MeSH Terms:
Disability Evaluation*
Recovery of Function*
Bipolar Disorder/*psychology
Bipolar Disorder/*therapy
Acute Disease ; Antidepressive Agents/therapeutic use ; Antipsychotic Agents/therapeutic use ; Bipolar Disorder/epidemiology ; Cognition Disorders/epidemiology ; Combined Modality Therapy ; Humans ; Prognosis ; Psychotherapy ; Severity of Illness Index
Liczba referencji:
122
Substance Nomenclature:
0 (Antidepressive Agents)
0 (Antipsychotic Agents)
Entry Date(s):
Date Created: 20070330 Date Completed: 20070509 Latest Revision: 20220408
Update Code:
20240104
DOI:
10.1111/j.1399-5618.2007.00430.x
PMID:
17391360
Czasopismo naukowe
Bipolar disorders (BPD) are major, life-long psychiatric illnesses found in 2-5% of the population. Prognosis for BPD was once considered relatively favorable, but contemporary findings suggest that disability and poor outcomes are prevalent, despite major therapeutic advances. Syndromal recovery from acute episodes of mania or bipolar major depression is achieved in as many as 90% of patients given modern treatments, but full symptomatic recovery is achieved slowly, and residual symptoms of fluctuating severity and functional impact are the rule. Depressive-dysthymic-dysphoric morbidity continues in more than 30% of weeks in follow-up from initial episodes as well as later in the illness-course. As few as 1/3 of BPD patients achieve full social and occupational functional recovery to their own premorbid levels. Pharmacotherapy, though the accepted first-line treatment for BPD patients, is insufficient by itself, encouraging development of adjunctive psychological treatments and rehabilitative efforts to further limit morbidity and disability. Interpersonal, cognitive-behavioral, and psychoeducational therapies all show promise for improving symptomatic and functional outcomes. Much less is known about how these and more specific rehabilitative interventions might improve vocational functioning in BPD patients.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies